TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Alexion Pharma Nordics AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
269,323
|
261,559
|
234,166 |
Financial expenses |
1,798
|
40
|
173 |
Earnings before taxes |
12,462
|
7,791
|
9,750 |
EBITDA |
12,327
|
7,278
|
9,923 |
Total assets |
176,522
|
107,642
|
92,274 |
Current assets |
176,522
|
107,642
|
92,122 |
Current liabilities |
121,893
|
61,723
|
52,927 |
Equity capital |
54,629
|
45,919
|
39,347 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
14
|
15
|
16 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
30.9%
|
42.7%
|
42.6% |
Turnover per employee |
19,237
|
17,437
|
14,635 |
Profit as a percentage of turnover |
4.6%
|
3.0%
|
4.2% |
Return on assets (ROA) |
8.1%
|
7.3%
|
10.8% |
Current ratio |
144.8%
|
174.4%
|
174.1% |
Return on equity (ROE) |
22.8%
|
17.0%
|
24.8% |
Change turnover |
7,764
|
27,393
|
5,615 |
Change turnover % |
3%
|
12%
|
2% |
Chg. No. of employees |
-1
![]() |
-1
|
5 |
Chg. No. of employees % |
-7%
|
-6%
|
45% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.